Evidence map›Paper›PMID 39066441›Full record

ArticleVaccines2024

Overview of the Implementation of the First Year of Immunization against Human Papillomavirus across Different Administrative Units in Serbia and Montenegro.

Mirjana Štrbac, Milko Joksimović, Vladimir Vuković, Mioljub Ristić, Goranka Lončarević, Milena Kanazir, Nataša Nikolić, Tatjana Pustahija, Smiljana Rajčević, Stefan Ljubičić and 3 more

Abstract read
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mirjana ŠtrbacInstitute of Public Health of Vojvodina, Futoška 121, 21000 Novi Sad, Serbia.ORCID 0000-0003-1532-5548
Milko JoksimovićInstitute of Public Health of Montenegro, Džona Džeksona bb, 81110 Podgorica, Montenegro.
Vladimir VukovićInstitute of Public Health of Vojvodina, Futoška 121, 21000 Novi Sad, Serbia.ORCID 0000-0002-9561-7825
Mioljub RistićInstitute of Public Health of Vojvodina, Futoška 121, 21000 Novi Sad, Serbia.ORCID 0000-0002-6923-189X
Goranka LončarevićInstitute of Public Health of Serbia "Dr Milan Jovanović Batut", 11000 Belgrade, Serbia.
Milena KanazirInstitute of Public Health of Serbia "Dr Milan Jovanović Batut", 11000 Belgrade, Serbia.
Nataša NikolićInstitute of Public Health of Vojvodina, Futoška 121, 21000 Novi Sad, Serbia.ORCID 0009-0009-7973-1503
Tatjana PustahijaInstitute of Public Health of Vojvodina, Futoška 121, 21000 Novi Sad, Serbia.
Smiljana RajčevićInstitute of Public Health of Vojvodina, Futoška 121, 21000 Novi Sad, Serbia.
Stefan LjubičićInstitute of Public Health of Vojvodina, Futoška 121, 21000 Novi Sad, Serbia.
Marko KoprivicaInstitute of Public Health of Vojvodina, Futoška 121, 21000 Novi Sad, Serbia.
Dragan LauševićInstitute of Public Health of Montenegro, Džona Džeksona bb, 81110 Podgorica, Montenegro.
Vladimir PetrovićInstitute of Public Health of Vojvodina, Futoška 121, 21000 Novi Sad, Serbia.ORCID 0000-0002-2052-6232

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the availability of a safe and effective vaccination, uptake of human papillomavirus (HPV) vaccination remains low worldwide. We aimed to analyze the coverage of HPV immunization during the first year of the immunization program and the sociodemographic characteristics across different administrative units in Serbia and Montenegro. Coverage of HPV vaccination in Serbia for females aged 9-14 and 15-19 years was 5.5% and 5.9%, respectively. The coverage rate of immunization against HPV in Montenegro for girls aged 9-14 years was 22.1%. Within Serbia, only one administrative region (Moravica) had HPV immunization coverage in girls 9-19 years old above 10%, 11 districts had coverage from 5 to 10%, while 13 districts had coverage below 5%. As per Montenegro, two administrative units, Cetinje and Berane, reported the highest coverage, with 39% and 36.4% of vaccinated eligible girls, respectively. When we explored the coverage of HPV immunization among girls aged 9-19 years across different regions in Serbia, we observed that the level of coverage did not correlate with the number of pediatricians or with the population density. In Montenegro, we observed a similar situation. On the other hand, we noticed a statistically significant moderate negative correlation (r = -0.446;

Indexed as

HPV vaccinehuman papillomavirusMontenegrooncologypreventionSerbia

Identifiers

PMID39066441
PMCPMC11281365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.